Acute Myeloid Leukemia with 8:21 Translocation and Aberrant B-Marker Expression. Biomedical Research and Therapy, [S. l.], v. 10, n. 8, p. 5804–5809, 2023. DOI: 10.15419/bmrat.v10i8.822. Disponível em: https://preservation.bmrat.org/index.php/BMRAT/article/view/822.. Acesso em: 15 nov. 2024.